GB1253500A - Method of contraception - Google Patents

Method of contraception

Info

Publication number
GB1253500A
GB1253500A GB0714/71A GB171471A GB1253500A GB 1253500 A GB1253500 A GB 1253500A GB 0714/71 A GB0714/71 A GB 0714/71A GB 171471 A GB171471 A GB 171471A GB 1253500 A GB1253500 A GB 1253500A
Authority
GB
United Kingdom
Prior art keywords
gestagen
esters
action
dose
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB0714/71A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1253500A publication Critical patent/GB1253500A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

1,253,500. Contraceptive method. SCHERING A.G. 19 April, 1968 [19 April, 1967], No. 1714/71. Divided out of 1,231,412. Heading A5B. A method of contraception comprises the administration to a human female, parenterally or by implantation, of a gestagen free from oestrogens in a dose as hereinafter defined in any single menstrual cycle. The gestagen dosage is defined as that having an effect on the cervical mucus which corresponds to that produced by 1 to 20 mg. of 19-nor-17α-hydroxy progesterone caproate when administered in the same way. The term "gestagen" refers to progestational hormones (progestogens or progestins) having a pituitary hypothalamic inhibiting action or which have such action only at a dose above the minimum dose which produces gestagenic action. Typical compounds are: progesterone; its 3-enol esters and 17α-hydroxy-deviations, the 17-esters of 6α- methyl-17α-hydroxy progesterone and 17α- ethynyl-18-homo-19-nor-testosterone and its esters.
GB0714/71A 1967-04-19 1968-04-19 Method of contraception Expired GB1253500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC040583 1967-04-19

Publications (1)

Publication Number Publication Date
GB1253500A true GB1253500A (en) 1971-11-17

Family

ID=7435756

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1231412D Expired GB1231412A (en) 1967-04-19 1968-04-19
GB0714/71A Expired GB1253500A (en) 1967-04-19 1968-04-19 Method of contraception

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB1231412D Expired GB1231412A (en) 1967-04-19 1968-04-19

Country Status (6)

Country Link
US (1) US3758687A (en)
BE (1) BE713958A (en)
DE (1) DE1617839A1 (en)
FR (1) FR8061M (en)
GB (2) GB1231412A (en)
NL (1) NL6805612A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171358A (en) * 1974-04-19 1979-10-16 Eli Lilly And Company Novel contraceptive method
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5433219A (en) * 1992-09-23 1995-07-18 Spery; Nanette S. Receptive condom assembly
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
US9844558B1 (en) 2015-04-30 2017-12-19 Amag Pharmaceuticals, Inc. Methods of reducing risk of preterm birth
WO2017059070A1 (en) 2015-09-29 2017-04-06 Amag Pharmaceuticals, Inc. Crystalline and amorphous form of 17-a- hydroxyprogesterone caproate

Also Published As

Publication number Publication date
BE713958A (en) 1968-10-21
GB1231412A (en) 1971-05-12
FR8061M (en) 1970-07-06
US3758687A (en) 1973-09-11
DE1617839A1 (en) 1971-04-08
NL6805612A (en) 1968-10-21

Similar Documents

Publication Publication Date Title
US4066757A (en) Oral contraceptive regimen
SE7416039L (en)
ATE114116T1 (en) CONTINUOUS ADMINISTRATION OF LUTEINIZING HORMONE-RELEASING HORMONE IN COMBINATION WITH SEXSTEROID ADMINISTRATION AS A CONTRACEPTIVE METHOD.
US3755573A (en) Fertility control empoying quinestrol and quingestanol acetate
DK365887D0 (en) COMBINATION DOSAGE FOR HORMONE TREATMENT OF WOMEN IN PRAE-MENOPAUSUS
Ulmann Uses of RU 486 for contragestion: an update
GB1253500A (en) Method of contraception
Kind et al. Anti-ovulatory activity of subcutaneously injected steroids in the adult oestrus rabbit
Glasier Emergency contraception: time for de-regulation?
McPherson 3rd et al. Effects of various progestational preparations on gonadotropin secretion in ovariectomized immature female rats
US4171358A (en) Novel contraceptive method
Kurzrok The prospects for hormonal sterilization
Shearman Oral contraceptive agents
Howie The progestogen-only pill
Goldzieher Symposium on steroid hormones. 1. Synthetic progestational steroids. Their significance and use
MIXNER et al. Progesterone-like activity of some steroid compounds and of diethylstilbestrol in stimulating mammary lobule-alveolar growth
GB1312760A (en) Method of contraception
Roland Wy 3707, a totally synthesized progestogen for contraception
Haspels Post-coital oestrogen in large doses
GB1214712A (en) Contraceptive preparations
Jeppsson Background, development and properties of progestagens, with special reference to medroxyprogesterone acetate (MPA)
Karim et al. Injectable steroids as a method of contraception
Swyer Progestogens and their clinical uses: Part I
Elstein Low-dose progestagens as contraceptive agents
Fang et al. Progesterone retention by rat uterus I: Pharmacokinetics after uterine intraluminal instillation

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee